Med BioGene - News Archives 2006

Featured News

February 17, 2010

Med BioGene Announces Results of Annual and Special Meeting

January 20, 2010

Med BioGene Announces Date of Annual and Special Meeting and Adoption of Shareholder Rights Plan

January 18, 2010

Med BioGene Appoints World-Renowned Genticist Dr. Michael R. Hayden as Director

December 29, 2009

Med BioGene Files Registration Statement for Proposed U.S. IPO

December 03, 2009

Med BioGene Announces Poster Presentations of LungExpress Dx™ Validation Study and Health Economics Evaluation at AACR – IASLC Meeting in January

October 15, 2009

Med BioGene Announces Positive Results from Validation Study of LungExpess Dx™

August 17, 2009

Med BioGene Reports Financial Results for the Second Quarter 2009

July 16, 2009

Med BioGene and the University of Ottawa Heart Institute Publish Study Demonstrating Potential New Diagnostic and Therapeutic Gene Expression Markers for Coronary Artery Disease

July 14, 2009

Med BioGene Increases Private Placement

June 25, 2009

Med BioGene Announces Closing of Second Tranche of Private Placement

June 05, 2009

Med BioGene Announces Closing of First Tranche of Private Placement

April 22, 2009

Med BioGene Announces Private Placement and Lead Order

March 18, 2009

Med BioGene Expands Collaboration with University Health Network for Novel Gene Markers Predictive of Chemotherapy Response in Lung Cancer

March 16, 2009

Med BioGene Appoints Life Science Veteran as Chief Financial Officer

News Archives

2006

News Archives 2006

April 30, 2007

Med BioGene Inc. Reports Financial Results for 2006

November 29, 2006

Med BioGene Appoints John H. Rayson, M.D. as Chairman of the Board; Reports Financial Results for Third Quarter 2006

September 25, 2006

Med BioGene Enters Development and Validation Phase for its Cardiovascular Disease Profiling System™; Begins Joint Pilot Project with Ottawa Heart Institute Research Corporation

September 19, 2006

Med BioGene to Present at BioContact Québec 2006 in Québec City

August 29, 2006

Med BioGene Inc. Reports Financial Results for Second Quarter 2006

August 03, 2006

Med BioGene Reports Promising Pre-Clinical Results of its Diagnostic Lymphoma DNA Bioarray; Biomarkers Effective in Diagnosing Major Lymphoma Subtypes

August 01, 2006

Med BioGene Inc. Receives Renewed Ethics Board Approval from Vancouver Coastal Health Authority; Expects to Release Pre-Clinical Results of Diagnostic Lymphoma Bioarray Shortly

July 11, 2006

Med BioGene Inc.’s Chief Scientific Officer to Present at Prestigious P.O.E.T.I.C. Conference to be held July 19-21 in Banff, Alberta

June 30, 2006

Med BioGene Inc. Receives Ethics Board Approval from the Ontario Cancer Research Ethics Board; Signs Material Transfer Agreement with the Ontario Institute for Cancer Research

June 23, 2006

Med BioGene Inc. Signs Letter of Intent with the Ontario Institute for Cancer Research

June 05, 2006

Med BioGene Inc. Appoints Bruce Cousins as a Director

May 30, 2006

Med BioGene Inc. Reports Financial Results for First Quarter 2006

May 19, 2006

Med BioGene Inc. Appoints Erinn B. Broshko as its New Chief Executive Officer and a Director

May 18, 2006

Med BioGene Inc. Reports Financial Results for Fiscal Year 2005

May 05, 2006

Med BioGene Inc. Completes Acquisition of Dragon-Tex (Group) Limited and Dragon-Tex (Group) Limited and $2 Million Financing